Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HD-tDCS to Modulate Connectivity

NCT: NCT05959551 · RECRUITING

NCT IDNCT05959551
StatusRECRUITING
Start Date2023-07-01
Completion2026-08-31

Brief Summary

The purpose of the proposed study is to broaden our understanding on the neural effects of High Definition Transcranial Direct Current Stimulation (HD-tDCS) so that its clinical effects can be further improved.

Frequently Asked Questions

What is HD-tDCS to Modulate Connectivity?

HD-tDCS to Modulate Connectivity is a clinical trial registered under NCT05959551. Current status: RECRUITING.

What is the status of NCT05959551?

The current status of NCT05959551 (HD-tDCS to Modulate Connectivity) is: RECRUITING.

When did HD-tDCS to Modulate Connectivity start?

HD-tDCS to Modulate Connectivity started on 2023-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.